In GC, HGB levels were significantly lower in patients with lung disease than in those with nasal (p = 0.0102), pharyngeal (p = 0.0181), laryngeal (p = 0.0158), and tracheobronchial (p = 0.0127) diseases. This evidence concerns the gene CYGB and lung disorder.